Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana L Blithe

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Frontiers in Reproductive Health|July 24, 2023
Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptabilityMary Kate Shapley-Quinn, Mei Song, Beatrice A Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 2, 2022
Dimethandrolone, a Potential Male Contraceptive Pill, is Primarily Metabolized by the Highly Polymorphic UDP-Glucuronosyltransferase 2B17 Enzyme in Human Intestine and LiverSheena Sharma, Deepak Ahire, Abdul Basit, et al.
The Journal of Clinical Endocrinology and Metabolism|October 22, 2020
Dimethandrolone Undecanoate, a Novel, Nonaromatizable Androgen, Increases P1NP in Healthy Men Over 28 DaysArthi Thirumalai, Fiona Yuen, John K Amory, et al.
Contraception|December 4, 2016
Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiomeJ Paul Brooks, David J Edwards, Diana L Blithe, et al.
Contraception|July 2, 2014
Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trialMara Y Roth, Grace Shih, Niloufar Ilani, et al.
Contraception|April 17, 2022
Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimensCarolyn L Westhoff, David F Archer, Kurt Barnhart, et al.
Contraception|August 10, 2019
Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trialsCarolina Sales Vieira, Ian S Fraser, Marlena G Plagianos, et al.
Andrology|December 9, 2024
Evaluation of dimethandrolone undecanoate in non-human primates as a candidate for long-acting injectable male contraceptiveDeborah I Bunin, Kyuri Kim, Toufan Parman, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 2012
A new combination of testosterone and nestorone transdermal gels for male hormonal contraceptionNiloufar Ilani, Mara Y Roth, John K Amory, et al.
Andrology|April 28, 2021
Comparison of metabolic effects of the progestational androgens dimethandrolone undecanoate and 11β-MNTDC in healthy menFiona Yuen, Arthi Thirumalai, Frances A Fernando, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Reproductive Health|July 24, 2023
Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptabilityMary Kate Shapley-Quinn, Mei Song, Beatrice A Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 2, 2022
Dimethandrolone, a Potential Male Contraceptive Pill, is Primarily Metabolized by the Highly Polymorphic UDP-Glucuronosyltransferase 2B17 Enzyme in Human Intestine and LiverSheena Sharma, Deepak Ahire, Abdul Basit, et al.
The Journal of Clinical Endocrinology and Metabolism|October 22, 2020
Dimethandrolone Undecanoate, a Novel, Nonaromatizable Androgen, Increases P1NP in Healthy Men Over 28 DaysArthi Thirumalai, Fiona Yuen, John K Amory, et al.
Contraception|December 4, 2016
Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiomeJ Paul Brooks, David J Edwards, Diana L Blithe, et al.
Contraception|July 2, 2014
Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trialMara Y Roth, Grace Shih, Niloufar Ilani, et al.
Contraception|April 17, 2022
Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimensCarolyn L Westhoff, David F Archer, Kurt Barnhart, et al.
Contraception|August 10, 2019
Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trialsCarolina Sales Vieira, Ian S Fraser, Marlena G Plagianos, et al.
Andrology|December 9, 2024
Evaluation of dimethandrolone undecanoate in non-human primates as a candidate for long-acting injectable male contraceptiveDeborah I Bunin, Kyuri Kim, Toufan Parman, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 2012
A new combination of testosterone and nestorone transdermal gels for male hormonal contraceptionNiloufar Ilani, Mara Y Roth, John K Amory, et al.
Andrology|April 28, 2021
Comparison of metabolic effects of the progestational androgens dimethandrolone undecanoate and 11β-MNTDC in healthy menFiona Yuen, Arthi Thirumalai, Frances A Fernando, et al.
Pageof 6